logo

3BBLACKBIO vs ACUTAAS: Stock Comparison

3B BLACKBIO DX vs ACUTAAS CHEMICALSUpdated 19 Oct 26, 4:08 PM ISTNSE & company filings

ACUTAAS CHEMICALS is the larger company by market capitalisation. 3B BLACKBIO DX shows a lower P/E, a higher dividend yield and a higher net margin, while ACUTAAS CHEMICALS shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

3BBLACKBIO leads 5; ACUTAAS leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

3BBLACKBIOACUTAAS

Valuation lens

What price are you paying?

Market CapContext only
₹1,143 Cr
₹26,63,595.08 L Cr
P/E Ratio3BBLACKBIO has the lower reading
20.58x ✓
69.01x
P/B Ratio3BBLACKBIO has the lower reading
3.52x ✓
16.12x
EPSACUTAAS has the higher reading
₹11.11
₹47 ✓
Book ValueContext only
₹386.41
₹201.93
Dividend Yield3BBLACKBIO has the higher reading
0.38% ✓
0.08%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ACUTAAS is the larger company
₹26,63,595.08 L Cr vs ₹1,143 Cr
P/E Ratio
3BBLACKBIO has a lower P/E
20.58x vs 69.01x
P/B Ratio
3BBLACKBIO has a lower P/B
3.52x vs 16.12x
EPS
ACUTAAS has higher earnings per share
₹47 vs ₹11.11
Dividend Yield
3BBLACKBIO has a higher dividend yield
0.38% vs 0.08%
Revenue Growth (TTM YoY)
ACUTAAS has faster revenue growth
40.3% vs 0%
EPS Growth (TTM YoY)
ACUTAAS has faster EPS growth
105.6% vs 0%
Qtr Sales Growth
ACUTAAS has stronger quarterly sales growth
0% vs -5.48%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

Metric3BBLACKBIOACUTAAS
Sector—Healthcare
Industry—Pharmaceuticals

Price

Metric3BBLACKBIOACUTAAS
Live Price₹1,331.2₹3,253.4
Day Change-7.96%1.48%
Volume43,4435.57 L
52-Week High₹1,740₹3,740
52-Week Low₹1,085₹1,570
Distance from 52W High-23.49%-13.01%

Valuation

Metric3BBLACKBIOACUTAAS
Market Cap₹1,143 Cr₹26,63,595.08 L Cr
P/E Ratio20.58x69.01x
P/B Ratio3.52x16.12x
EPS₹11.11₹47
Book Value₹386.41₹201.93
Dividend Yield0.38%0.08%

Growth

Metric3BBLACKBIOACUTAAS
Revenue Growth (TTM YoY)0%40.3%
EPS Growth (TTM YoY)0%105.6%
Qtr Sales Growth-5.48%0%
Qtr Profit Growth-8.43%0%

Profitability & Leverage

Metric3BBLACKBIOACUTAAS
ROE18.07%21.95%
ROCE17.44%24.04%
Net Margin42.23%26.6%
Operating Margin54.4%37.46%
Debt to Equity0.01x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
Metric3BBLACKBIOACUTAAS
Promoter Holding38.48%▲ 0.02 pp32.66%
FII Holding2.5%▼ 0.07 pp22.62%▲ 1.01 pp
DII Holding2.15%▲ 0.17 pp19.4%▼ 0.16 pp
Public Holding54.4%▼ 0.11 pp25.31%▼ 0.85 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: 3B BLACKBIO DX and ACUTAAS CHEMICALS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.